Summary
Joint Strategic Collaboration between Johnson & Johnson and Crucell for influenza prevention and Treatment can open up new avenues by joint Joint research & clinical Trial programmes.
Analysis
The need of hour is to have a constant Health System Research in area of Influenza prevention & treatment for an effective Health outcome, as threat of Swine flu becoming a Global Pandemic is on the door,rising Mortality rate from Flu, this possibly can be overcome by joint research Strategic collaborations as done between Johnson & Johnson & Crucell. It will provide very Fruitful results in Global Influenza Management as it will provide new options for Anti-influenza Vaccines & Better Influenzal Antiviral Drugs.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
